These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9107)

  • 1. [Interactions of dopamine receptor agonists and antagonists with regard to dopamine synthesis and metabolism].
    Kehr W
    Arzneimittelforschung; 1976; 26(6):1086-8. PubMed ID: 9107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of (+) amphetamine on monoamine synthesis and metabolism after axotomy in rat forebrain.
    Speckenbach W; Kehr W
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):25-30. PubMed ID: 1087702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of haloperidol and gamma-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain.
    Kehr W; Speckenbach W; Zimmermann R
    J Neural Transm; 1977; 40(2):129-47. PubMed ID: 323421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
    Pehek EA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.
    Lappalainen J; Hietala J; Koulu M; Seppälä T; Sjöholm B; Syvälahti E
    J Pharmacol Exp Ther; 1990 Feb; 252(2):845-52. PubMed ID: 2179533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine-haloperidol interactions on striatal and mesolimbic tyrosine hydroxylase activity and dopamine metabolism.
    Kuczenski R
    J Pharmacol Exp Ther; 1980 Oct; 215(1):135-42. PubMed ID: 6109012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of in vivo amphetamine administration on dopamine synthesis regulation in rat brain striatal synaptosomes.
    Patrick RL; Berkowitz AL; Regenstein AC
    J Pharmacol Exp Ther; 1981 Jun; 217(3):686-91. PubMed ID: 7229999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons.
    Berry SA; Gudelsky GA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):677-82. PubMed ID: 1974647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
    Richard MG; Bennett JP
    Exp Neurol; 1994 Sep; 129(1):57-63. PubMed ID: 7925842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
    Johnson EA; Tsai CE; Shahan YH; Azzaro AJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):133-41. PubMed ID: 8101215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.
    Sotty F; Montezinho LP; Steiniger-Brach B; Nielsen J
    J Neurochem; 2009 May; 109(3):766-75. PubMed ID: 19236563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
    Bongiovanni R; Young D; Newbould E; Jaskiw GE
    Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of haloperidol and d-amphetamine on in vivo 3H-spiroperiodol binding in the rat forebrain(1).
    Saelens JK; Simke JP; Neale SE; Weeks BJ; Selwyn M
    Arch Int Pharmacodyn Ther; 1980 Jul; 246(1):98-107. PubMed ID: 7447553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anorexigenic effects of d-amphetamine and l-DOPA in the rat.
    Sanghvi IS; Singer G; Friedman E; Gershon S
    Pharmacol Biochem Behav; 1975; 3(1):81-6. PubMed ID: 1129359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
    J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.